The percentages of the patients whose GAD and PHQ scores were greater or equal to 3 are almost the same in patients with different tumor sizes (average of 33% and 32% in order), which means that tumor size was not an important factor in increasing the risk of the patient's anxiety and depression. The gene discussed is GAD1; the disease is depressive symptom measurement.